|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.58 USD | +3.27% |
|
+4.22% | -25.67% |
| 06-09 | EyePoint, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 11:20 AM | |
| 05-14 | EyePoint's late-stage eye drug trials to continue after safety panel review | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- EYPT Stock
- Consensus EyePoint, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
